{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/CSE/DRUG", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Bright Minds Biosciences Inc. (CSE: DRUG) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Bright Minds Biosciences Inc., listed on the CSE under the ticker DRUG. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. The security type is Corporate, the sector is Life Sciences, and the segment and jurisdiction are not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 17 filings in the twelve months to 2026-11-06, all of them newswire releases, across 13 filing days. The median gap between filing days is 9.5 days. The latest filing is a newswire release dated 2026-11-04, 2 days before the record date. The CSE peer median gap is 19.5 days, and the Life Sciences sector peer median gap is 17.5 days. The CSE peer median filings count is 6.0 and the sector peer median is 7.0. The CSE peer median latency is 17.0 days and the sector peer median latency is 14 days.\n\n## Auditor\n\nThe auditor of record is DeVisser Gray LLP, and its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag shows the issuer as listed, not halted.\n\n## Orderability\n\nUnder paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.\n\n## Open research\n\nThe field has not been read, so the count of openly published research notes is not on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. The live record began on 2026-09-10, and the market's earliest sealed date is not on the record.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://mcp.ca-cm-kg.ai/events/CSE/DRUG (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/bright-minds-biosciences-inc/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/DRUG (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "CSE · adjudicated by Claude", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/listings/bright-minds-biosciences-inc/", "state": "filled", "value": "DeVisser Gray LLP" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/CSE/DRUG", "coverage": { "note": "the coverage field has not been read for this issuer", "state": "not_read" }, "disclosure": { "against": { "exchange": { "issuers": 724, "median_cadence_gap_days": 19.5, "median_filings": 6, "median_latency_days": 17, "name": "CSE" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "newswire_release": 17 }, "cadence_median_gap_days": 9.5, "filing_days": 13, "filings": 17, "latency_days": 2, "latest": [ { "category": null, "date": "2026-11-04", "source": "https://www.globenewswire.com/news-release/2026/11/04/3395729/937/en/bright-minds-biosciences-investigation-drug-securities-investors-encouraged-to-contact-kirby-mcinerney-llp-about-their-rights.html", "title": "BRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG Securities", "type": "newswire_release" }, { "category": null, "date": "2026-11-04", "source": "https://www.globenewswire.com/news-release/2026/11/04/3395729/0/en/bright-minds-biosciences-investigation-drug-securities-investors-encouraged-to-contact-kirby-mcinerney-llp-about-their-rights.html", "title": "BRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG ...", "type": "newswire_release" }, { "category": null, "date": "2026-11-03", "source": "https://www.prnewswire.com/news-releases/drug-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-bright-minds-biosciences-302928125.html", "title": "DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences", "type": "newswire_release" }, { "category": null, "date": "2026-11-02", "source": "https://www.prnewswire.com/news-releases/bright-minds-biosciences-investigation-notice-levi--korsinsky-notifies-investors-of-pending-investigation-into-bright-minds-biosciences-drug-302926911.html", "title": "Bright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG)", "type": "newswire_release" }, { "category": null, "date": "2026-11-02", "source": "https://www.globenewswire.com/news-release/2026/11/02/3393046/0/en/bright-minds-biosciences-provides-update-about-planned-study-with-bmb-101-in-developmental-and-epileptic-encephalopathies.html", "title": "Bright Minds Biosciences Provides Update About Planned", "type": "newswire_release" } ], "latest_filing_date": "2026-11-04", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/CSE/DRUG", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "CSE" }, "isin": { "market": "CA", "reason": "no ISIN found on issuer pages", "state": "not_on_record" }, "jurisdiction": { "market": "CA", "reason": "not searched", "state": "not_on_record" }, "lei": { "market": "CA", "reason": "no ISIN", "state": "not_on_record" }, "name": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Bright Minds Biosciences Inc." }, "sector": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "DRUG" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:08044a65bd37ec4a8c24f86a84df8515fe3831ce0c7aea53ed68e51bcd36018d", "open_research": { "rows": [], "state": "not_read" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/CSE/DRUG", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:08044a65bd37ec4a8c24f86a84df8515fe3831ce0c7aea53ed68e51bcd36018d", "path": "/ca/CSE/DRUG", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is Bright Minds Biosciences Inc., listed on the CSE under the ticker DRUG. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. The security type is Corporate, the sector is Life Sciences, and the segment and jurisdiction are not on the record. The listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 17 filings in the twelve months to 2026-11-06, all of them newswire releases, across 13 filing days. The median gap between filing days is 9.5 days. The latest filing is a newswire release dated 2026-11-04, 2 days before the record date. The CSE peer median gap is 19.5 days, and the Life Sciences sector peer median gap is 17.5 days. The CSE peer median filings count is 6.0 and the sector peer median is 7.0. The CSE peer median latency is 17.0 days and the sector peer median latency is 14 days.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is DeVisser Gray LLP, and its location is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag shows the issuer as listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "The field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.", "title": "Coverage" }, { "id": "open_research", "text": "The field has not been read, so the count of openly published research notes is not on the record.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. The live record began on 2026-09-10, and the market's earliest sealed date is not on the record.", "title": "As-of depth" }, { "id": "sources", "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://thecse.com/api/webapi/listed-companies/" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/CSE/DRUG" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the auditor", "source": "https://thecse.com/listings/bright-minds-biosciences-inc/" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/CSE/DRUG" } ], "title": "Bright Minds Biosciences Inc. (DRUG) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }